BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7534006)

  • 21. Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma.
    Tsang NM; Chuang CC; Tseng CK; Hao SP; Kuo TT; Lin CY; Pai PC
    Cancer; 2003 Dec; 98(11):2385-92. PubMed ID: 14635073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
    Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
    Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
    Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sequence analysis of the CTL epitopes in transmembrane region of latent membrane protein 2 of Epstein-Barr virus derived from nasopharyngeal carcinoma cells].
    Zhang NH; Zhang XS; Li J; Zhang RH; Gao YF; Zeng MS
    Ai Zheng; 2006 May; 25(5):566-9. PubMed ID: 16687075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of a 30-base pair deletion in the latent membrane protein-1 gene in Epstein-Barr virus-associated lymphomas in Japan.
    Hirose Y; Masaki Y; Kurose N
    Int J Hematol; 2000 Aug; 72(2):210-5. PubMed ID: 11039671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.
    Alkan S; Ross CW; Hanson CA; Schnitzer B
    Mod Pathol; 1995 Jun; 8(5):544-7. PubMed ID: 7675775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.
    Fielding CA; Sandvej K; Mehl A; Brennan P; Jones M; Rowe M
    J Virol; 2001 Oct; 75(19):9129-41. PubMed ID: 11533177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
    Tan EL; Peh SC; Sam CK
    J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of different clonal EBV strains in Hodgkin lymphoma and nasopharyngeal carcinoma tissues from the same patient.
    Rey J; Xerri L; Bouabdallah R; Keuppens M; Brousset P; Meggetto F
    Br J Haematol; 2008 Jul; 142(1):79-81. PubMed ID: 18422778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?
    Khan G; Gupta RK; Coates PJ; Slavin G
    Am J Pathol; 1993 Nov; 143(5):1270-4. PubMed ID: 8238244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogenes met and fes, tumor suppressor gene product p53, and interleukins 2 and 6.
    Krueger GR; Guenther A; Knuefermann R; Kluppelberg U; Luka J; Pearson GR; Ablashi DV; Juecker M; Tesch H
    In Vivo; 1994; 8(4):501-16. PubMed ID: 7893977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease.
    Knecht H; Bachmann E; Joske DJ; Sahli R; Eméry-Goodman A; Casanova JL; Zilić M; Bachmann F; Odermatt BF
    Leukemia; 1993 Apr; 7(4):580-5. PubMed ID: 8464236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D; Srivatanakul P; Karalak A; Ishida T
    J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Hodgkin's disease Reed-Sternberg cells and normal B-lymphocytes are infected by related Epstein-Barr virus strains.
    Faumont N; Trempat P; Brousset P; Delsol G; Meggetto F
    Virus Res; 2004 May; 101(2):163-73. PubMed ID: 15041184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.